Placebo Matched to Elafibranor 120 mg clinical trials

A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.

This study is looking at a new medicine called elafibranor for people with a liver condition called Primary Sclerosing Cholangitis (PSC). We want to see if it's safe and helps improve the condition, comparing it to a dummy treatment.